| 中文名 | 4-((1-(4-氯苄基)-3-羟基-2-氧-2-氧-1,2-二氢吡啶-4-基)甲基)哌嗪-1-甲酸叔丁酯 |
|---|---|
| 英文名 | tert-Butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate |
| 中文别名 |
4-[(4-BOC-1-哌嗪基)甲基]-1-(4-氯苄基)-3-羟基吡啶-2(1H)-酮
4-((1-(4-氯苄基)-3-羟基-2-氧代-1,2-二氢吡啶-4-基)甲基)哌嗪-1-甲酸叔丁酯 |
| 英文别名 |
tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-cboxylate
4-[1-(4-Chloro-benzyl)-3-hydroxy-2-oxo-1,2-dihydro-pyridin-4-ylmethyl]-piperazine-1-cboxylic acid tert-butyl ester 1-Piperazinecboxylic acid, 4-[[1-[(4-chlorophenyl)methyl]-1,2-dihydro-3-hydroxy-2-oxo-4-pyridinyl]methyl]-, 1,1-dimethylethyl ester tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydr tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-cboxylate 4-[(4-Boc-1-piperazinyl)methyl]-1-(4-chlorobenzyl)-3-hydroxypyridin-2(1H)-one Izilendustat, 10 mM in DMSO tert-butyl 4-({1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl}methyl)piperazine-1-cboxylate inmmune response,HIF-PH,colitis,prolyl hydroxylase,Inhibitor,HIF-2,HIFs,Hypoxia-inducible factors,inflammatory bowel diseases,HIF/HIF Prolyl-Hydroxylase,Izilendustat,inhibit,HIF- lα |
| 描述 | Izilendustat是脯氨酰羟化酶的有效抑制剂,可稳定缺氧诱导因子-1α(HIF-lα)和缺氧诱导因子-2(HIF-2)。Izilendustat有潜力研究与身体免疫反应有关的疾病,如结肠炎和其他炎症性肠病(摘自专利WO2011057115A1和WO2011057121A1)[1][1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
[1]. Joseph H, et al. Prolyl hydroxylase inhibitors. Patent WO2011057115A1. [2]. Joseph H, et al. Compositions and methods for treating colitis. Patent WO2011057121A1. |
| 分子式 | C22H28ClN3O4 |
|---|---|
| 分子量 | 433.93 |
| 储存条件 | 2-8°C |